Jacob Borrajo
Amministratore Delegato presso Amber Bio, Inc.
Profilo
Jacob Borrajo is the founder of Coral Genomics, Inc. Mr. Borrajo is also the founder of Amber Bio, Inc.
Posizioni attive di Jacob Borrajo
| Società | Posizione | Inizio |
|---|---|---|
Amber Bio, Inc.
 Amber Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Amber Bio, Inc. is a biotechnology company based in an undisclosed location. The American company is focused on developing a first-of-its-kind RNA editing platform that can correct genetic mutations in a safe and reversible way. Amber Bio is pioneering new gene editing modalities using multi-kilobase RNA writing to reach previously undruggable diseases. Co-founders Jacob Borrajo and Basem Al-Shayeb received their Ph.D. at leading institutions for gene editing research: Broad Institute of MIT & Harvard and University of California. Jacob Borrajo has been the CEO since incorporation. | Amministratore Delegato | - |
Precedenti posizioni note di Jacob Borrajo
| Società | Posizione | Fine |
|---|---|---|
Coral Genomics, Inc.
 Coral Genomics, Inc. Pharmaceuticals: MajorHealth Technology Coral Genomics, Inc. operates as a biotechnology company that optimizes drug development and deployment by utilizing genomic data from patients. The company was founded by Jacob Borrajo and Atray Dixit in 2018 and is headquartered in San Francisco, CA. | Fondatore | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Coral Genomics, Inc.
Coral Genomics, Inc. Pharmaceuticals: MajorHealth Technology Coral Genomics, Inc. operates as a biotechnology company that optimizes drug development and deployment by utilizing genomic data from patients. The company was founded by Jacob Borrajo and Atray Dixit in 2018 and is headquartered in San Francisco, CA. | Health Technology |
Amber Bio, Inc.
Amber Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Amber Bio, Inc. is a biotechnology company based in an undisclosed location. The American company is focused on developing a first-of-its-kind RNA editing platform that can correct genetic mutations in a safe and reversible way. Amber Bio is pioneering new gene editing modalities using multi-kilobase RNA writing to reach previously undruggable diseases. Co-founders Jacob Borrajo and Basem Al-Shayeb received their Ph.D. at leading institutions for gene editing research: Broad Institute of MIT & Harvard and University of California. Jacob Borrajo has been the CEO since incorporation. | Commercial Services |
- Borsa valori
- Insiders
- Jacob Borrajo
